Authors:
LIBERATI AM
VERDUCCI N
BETTI AR
ALSHARJABY N
ROMANO R
GENUA A
STIVAKTAKI A
TROTTINI M
SCHIPPA M
METTIVIER V
DONTI E
Citation: Am. Liberati et al., IFN-ALPHA THERAPY FOR CHRONIC MYELOID-LEUKEMIA - A SINGLE-CENTER EXPERIENCE, British Journal of Haematology, 102(1), 1998, pp. 187-187
Authors:
LIBERATI AM
TROTTINI M
GENUA A
ROMANO R
STIVAKTAKI A
SCHIPPA M
BETTI AR
ALSHARJABY N
METTIVIER V
MOSCHINI TO
NICOLI P
MESSINA S
PALUMBO B
PALUMBO R
Citation: Am. Liberati et al., EVALUATION OF RESPONSE TO THERAPY WITH GA-67 SCINTIGRAPHY, CT SCAN AND MAGNETIC-RESONANCE IN MALIGNANT-LYMPHOMAS, British Journal of Haematology, 102(1), 1998, pp. 246-246
Authors:
LIBERATI AM
DEANGELIS V
STIVAKTAKI A
ROMANO R
BETTI AR
CINIERI S
SCHIPPA M
SAGLIO G
Citation: Am. Liberati et al., ANALYSIS OF FACTORS THAT INFLUENCE STEM-CELL YIELD IN PATIENTS WITH HEMATOLOGIC NEOPLASIAS, Blood, 90(10), 1997, pp. 4233-4233
Authors:
LIBERATI AM
BETTI AR
MANCINI S
DICLEMENTE F
GENUA A
ADAMO S
GEMINI M
BOCCANERA A
CARICCHI P
Citation: Am. Liberati et al., IDARUBICIN, CYCLOPHOSPHAMIDE, VINCRISTINE AND METHYLPREDNISOLONE FOLLOWED BY G-CSF IN THE TREATMENT OF ADVANCED MULTIPLE-MYELOMA, European journal of cancer, 31A, 1995, pp. 252-252
Authors:
FERRAJOLI A
LIBERATI AM
CARICCHI P
DONTI E
MORRA E
LAZZARINO M
BETTI AR
BERNASCONI P
SAGLIO G
Citation: A. Ferrajoli et al., INTERFERON-ALPHA PLUS LOW-DOSE CYTOSINE-ARABINOSIDE IN ADVANCED PHASECHRONIC MYELOGENOUS LEUKEMIA PATIENTS, European journal of haematology, 55(3), 1995, pp. 184-188
Authors:
LIBERATI AM
GAROFANI P
DEANGELIS V
DICLEMENTE F
HORISBERGER M
CECCHINI M
BETTI AR
PALMISANO L
ASTOLFI S
NASTARI A
VILLA A
ARZANO S
Citation: Am. Liberati et al., DOUBLE-BLIND RANDOMIZED PHASE-I STUDY ON THE CLINICAL TOLERANCE AND PHARMACODYNAMICS OF NATURAL AND RECOMBINANT INTERFERON-BETA GIVEN INTRAVENOUSLY, Journal of interferon research, 14(2), 1994, pp. 61-69